CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to GALDY

Phase 3

Development Phase

2

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q4 '27
GALDYPhase 3

Nemolizumab Phase 3 Est. Readout

Nemolizumab
Q4 2027~Q
CT.gov
00%
Dec '26
GALDYPhase 2
✓Positive

nemolizumab Phase 2 Est. Readout (CPUO)

Nemolizumab
Dec 2026~
CT.gov
Development History
Oct '26
GALDYPhase 3

Nemolizumab Phase 3 Est. Readout

Nemolizumab
Oct 2026~
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Prurigo Nodularis

Clinical Trial

NCT04204616

Last updated: 1/22/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.